Literature DB >> 6967184

Trimethoprim-sulfamethoxazole.

R H Rubin, M N Swartz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6967184     DOI: 10.1056/NEJM198008213030804

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  18 in total

1.  The use of antimicrobial drugs in office practice.

Authors:  M R Achong
Journal:  Can Fam Physician       Date:  1982-12       Impact factor: 3.275

Review 2.  Current concepts in the treatment of genitourinary tract disorders in the older individual.

Authors:  A Atala; M Amin
Journal:  Drugs Aging       Date:  1991-05       Impact factor: 3.923

3.  Five-year survey of changing patterns of susceptibility of bacterial uropathogens to trimethoprim-sulfamethoxazole and other antimicrobial agents.

Authors:  U Alon; G Davidai; M Berant; D Merzbach
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

Review 4.  Hematological side effects of co-trimoxazole.

Authors:  H Heimpel; A Raghavachar
Journal:  Infection       Date:  1987       Impact factor: 3.553

5.  Is Streptococcus pyogenes resistant or susceptible to trimethoprim-sulfamethoxazole?

Authors:  Asha C Bowen; Rachael A Lilliebridge; Steven Y C Tong; Robert W Baird; Peter Ward; Malcolm I McDonald; Bart J Currie; Jonathan R Carapetis
Journal:  J Clin Microbiol       Date:  2012-10-10       Impact factor: 5.948

6.  Synergistic interaction of trimethoprim and sulfamethoxazole on Paracoccidioides brasiliensis.

Authors:  D A Stevens; P T Vo
Journal:  Antimicrob Agents Chemother       Date:  1982-05       Impact factor: 5.191

Review 7.  Cotrimoxazole. Rationale for re-examining its indications for use.

Authors:  R A Howe; R C Spencer
Journal:  Drug Saf       Date:  1996-04       Impact factor: 5.606

8.  Pneumocystis pneumonia in brain tumor patients: risk factors and clinical features.

Authors:  D Schiff
Journal:  J Neurooncol       Date:  1996-03       Impact factor: 4.130

Review 9.  Antibacterial therapy in patients with malignancies.

Authors:  K H Mayer; S M Opal
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

10.  Empiric antimicrobial therapy in febrile granulocytopenic patients. Randomized prospective comparison of amikacin plus piperacillin with or without parenteral trimethoprim/sulphamethoxazole.

Authors:  F Menichetti; A Del Favero; R Guerciolini; M Tonato; F Aversa; F Roila; R F Frongillo; M F Martelli; S Davis; S Pauluzzi
Journal:  Infection       Date:  1986 Nov-Dec       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.